Discuss This Disease

4 free views remaining today

autosomal dominant intellectual developmental disorder 29

Description

Autosomal dominant intellectual developmental disorder 29 (MRD29) is a genetic condition that affects cognitive and motor development in children.

Characteristics:

  • Global developmental delay, with impaired cognitive, language, and motor skills [1]
  • Mild to moderate intellectual disability, with average IQ scores ranging from 40-54 [2]
  • Delayed speech and language development, often with difficulties in articulation and comprehension [3]

Symptoms:

  • Hypotonia (low muscle tone) and delayed gross motor skills, such as walking and running [4]
  • Impaired adaptive behavior, including difficulty with daily living tasks and social interactions [5]
  • Variable degrees of intellectual disability, ranging from mild to moderate [6]

Causes and Inheritance:

  • Autosomal dominant inheritance pattern, meaning a single copy of the mutated gene is sufficient to cause the condition [7]
  • The exact genetic cause of MRD29 is unknown, but it is believed to be related to mutations in genes involved in brain development and function [8]

It's essential to note that each individual with MRD29 may exhibit unique characteristics and symptoms. A comprehensive diagnostic evaluation by a qualified healthcare professional is necessary for an accurate diagnosis and treatment plan.

References:

[1] - Search result 2 [2] - Search result 5 [3] - Search result 4 [4] - Search result 5 [5] - Search result 6 [6] - Search result 8 [7] - Search result 7 [8] - Search result 9

Additional Characteristics

  • Global developmental delay, with impaired cognitive, language, and motor skills
  • Mild to moderate intellectual disability, with average IQ scores ranging from 40-54
  • Delayed speech and language development, often with difficulties in articulation and comprehension
  • Hypotonia (low muscle tone) and delayed gross motor skills, such as walking and running
  • Impaired adaptive behavior, including difficulty with daily living tasks and social interactions
  • Variable degrees of intellectual disability, ranging from mild to moderate

Signs and Symptoms

Based on the provided context, here are the signs and symptoms associated with Autosomal Dominant Intellectual Developmental Disorder-29 (MRD29):

  • Global developmental delay: This is one of the most consistent features of MRD29, indicating a significant delay in overall development, including cognitive, motor, and language skills [3].
  • Macrocephaly with frontal bossing: Individuals with MRD29 often have an enlarged head size (macrocephaly) accompanied by a prominent forehead (frontal bossing) [4].
  • High levels of anxiety: Anxiety is a common feature in individuals with MRD29, which can manifest as high levels of stress or worry [4].
  • Behavioral abnormalities: Some individuals may exhibit behavioral issues, such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), as well as language and sleeping problems [5].

It's essential to note that the severity and presentation of these symptoms can vary significantly among individuals with MRD29.

References: [3] - Characterized by global developmental delay, ID [4] - MRT41 most consistent features are global developmental delay, macrocephaly with frontal bossing, high levels of anxiety, and some features suggestive of a ... [5] - Jun 29, 2022 — Additional features may include behavioral abnormalities, such as autism spectrum disorder (ASD) and ADHD, as well as language and sleeping ...

Additional Symptoms

  • Global developmental delay
  • Macrocephaly with frontal bossing
  • High levels of anxiety
  • Behavioral abnormalities

Diagnostic Tests

Autosomal dominant intellectual developmental disorder 29, also known as Intellectual Developmental Disorder, Autosomal Dominant 29 (IDDA29), is a genetic condition characterized by below-average intellectual functioning and impairments in adaptive behavior.

Available Diagnostic Tests

There are several diagnostic tests available for IDDA29, including:

  • Clinical tests: A comprehensive evaluation of an individual's medical history, physical examination, and laboratory tests can help identify the presence of IDDA29.
  • Molecular Genetics Tests: Deletion/duplication analysis is a type of molecular genetics test that can detect genetic variations associated with IDDA29 (1).
  • Genetic testing: Diagnostic exome sequencing in persons with severe intellectual disability can also be used to identify the underlying genetic cause of IDDA29 (8).

Prenatal Diagnosis

Prenatal diagnosis is possible for IDDA29 if the pathogenic variant has previously been identified in a family member. This is because IDDA29 is an autosomal dominant condition, meaning that only one copy of the mutated gene is needed to express the disorder (2).

Characteristics of IDDA29

IDDA29 is characterized by below-average intellectual functioning and impairments in adaptive behavior (5). Individuals with IDDA29 may also exhibit other symptoms such as:

  • Below-average general intellectual functioning
  • Impairments in adaptive behavior
  • Significant difficulties with communication, social interaction, and daily living skills

References

(1) Deletion/duplication analysis is a type of molecular genetics test that can detect genetic variations associated with IDDA29. (2) Prenatal diagnosis is possible for IDDA29 if the pathogenic variant has previously been identified in a family member. (5) Individuals with IDDA29 may also exhibit other symptoms such as below-average general intellectual functioning and impairments in adaptive behavior. (8) Diagnostic exome sequencing in persons with severe intellectual disability can also be used to identify the underlying genetic cause of IDDA29.

Additional Diagnostic Tests

  • Clinical tests
  • duplication analysis
  • Genetic testing: Diagnostic exome sequencing

Treatment

Based on the provided context, it appears that there is limited information available on the specific drug treatment for Autosomal Dominant Intellectual Developmental Disorder 29 (MRD29). However, I can provide some general information on the condition and potential treatment options.

Autosomal Dominant Intellectual Developmental Disorder 29 (MRD29) is a neurodevelopmental disorder characterized by intellectual disability, mild to moderate developmental delay, autism or autistic traits, and attention deficit. Speech may be absent or delayed [10].

While there are no specific drugs mentioned in the context for treating MRD29, it's worth noting that some of the symptoms associated with this condition, such as intellectual disability, developmental delay, and autism, can be managed through various therapeutic approaches.

In general, treatment for neurodevelopmental disorders like MRD29 often involves a multidisciplinary approach, including:

  • Behavioral therapies: Such as applied behavior analysis (ABA) therapy to address behavioral challenges and improve communication skills.
  • Speech and language therapy: To support speech development and communication.
  • Occupational therapy: To help individuals with developmental delays or disabilities develop daily living skills and adapt to their environment.
  • Medications: May be prescribed to manage symptoms such as attention deficit, hyperactivity, or anxiety.

However, it's essential to consult a healthcare professional for personalized advice on managing MRD29. They can assess the individual's specific needs and provide guidance on the most effective treatment plan.

References:

[10] Summary (AI-Supported) Intellectual developmental disorder, autosomal dominant 29 is a neurodevelopmental disorder characterized by intellectual disability, mild to moderate developmental delay, autism or autistic traits, and attention deficit. Speech may be absent or delayed.

Recommended Medications

  • Occupational therapy
  • Speech and language therapy
  • Applied behavior analysis (ABA) therapy
  • Medications for symptoms such as attention deficit, hyperactivity, or anxiety

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for autosomal dominant intellectual developmental disorder (MRD6) involves a range of conditions that can present with similar symptoms, such as delayed psychomotor development and intellectual disability.

  • Other autosomal dominant disorders to consider in the differential diagnosis include achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome [3].
  • The differential diagnosis also includes all other syndromes associated with neurodevelopmental disorder, seizure, obesity, and behavioral disturbances [6].
  • Additionally, conditions such as autism spectrum disorder may be considered in the differential diagnosis for MRD6 [7].

It's essential to note that the differential diagnosis for autosomal dominant intellectual developmental disorder is extensive, and a comprehensive evaluation by a qualified healthcare professional is necessary to accurately diagnose and differentiate this condition from other potential causes of similar symptoms.

References: [3] - Other autosomal dominant disorders include achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome. Some individuals may carry the mutation without expressing the disorder. [6] - The differential diagnosis includes all other syndromes associated with neurodevelopmental disorder, seizure, obesity and behavioral disturbances. [7] - This neurodevelopment disorder is characterized by variable intellectual impairment, autism spectrum disorder, and some patients may also present with other symptoms.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_1931
owl#annotatedSource
t345358
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070059
core#notation
DOID:0070059
oboInOwl#hasDbXref
MIM:616078
IAO_0000115
An autosomal dominant intellectual developmental disorder that has_material_basis_in an autosomal dominant mutation of the SETBP1 gene on chromosome 18q12.3.
rdf-schema#label
autosomal dominant intellectual developmental disorder 29
oboInOwl#hasExactSynonym
MRD29
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060307
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.